NORTHBROOK, Ill., March 11, 2024 /PRNewswire/ -- Astellas Pharma US, Inc. (TSE: 4503, President: Mark Reisenauer, "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has ...
The U.S. Food and Drug Administration (FDA) has issued two new draft guidance documents on pediatric drug development and exclusivity, most notably clarifying that, under a new proposed policy that ...
Please provide your email address to receive an email when new articles are posted on . The FDA today approved a pediatric dosage form of everolimus to treat subependymal giant cell astrocytoma. It is ...
WASHINGTON — Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new ...
One of the earliest disasters in modern pediatric drug therapy has, unfortunately, been the most repeated. In 1937, 2 years after adults had begun benefiting from sulfa antibiotics, an elixir of ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the Company’s supplemental New Drug ...
Changes in the regulatory environment in the United States and European Union have the potential to advance the concept of precision medicine to children with cancer. Preclinical testing of targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results